Targeted therapies: Afatinib--new therapy option for EGFR-mutant lung cancer.

Yu HA, Pao W
Nat Rev Clin Oncol. 2013 10 (10): 551-2

PMID: 23959269 · PMCID: PMC4665630 · DOI:10.1038/nrclinonc.2013.154

MeSH Terms (8)

Afatinib Carcinoma, Non-Small-Cell Lung ErbB Receptors Humans Lung Neoplasms Molecular Targeted Therapy Mutation Quinazolines

Connections (2)

This publication is referenced by other Labnodes entities:

Links